La vendita allo scoperto per ETC 6 Meridian Mega Cap Equity ETF dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di ETC 6 Meridian Mega Cap Equity ETF. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

ETC 6 Meridian Mega Cap Equity ETF (ARCA:SIXA), Report sulle vendite allo scoperto

Technology

Healthcare

Consumer Defensive

Consumer Cyclical

Industrials

Energy

Financial Services

Communication Services

Other

Real Estate

The Fund is an actively managed exchange-traded fund (ETF) that invests, under normal circumstances, at least 80 percent of its net assets (plus the amount of any borrowings for investment purposes) in mega capitalization equity securities. Madison Avenue Financial Solutions, LLC, the Funds sub-adviser (the Sub-Adviser), considers mega capitalization companies to be the largest 10 percent of stocks included in the Russell 3000 Index by market capitalization. The equity securities in which the Fund invests are mainly common stocks.

Kraft Heinz Co.

Johnson & Johnson

At&t Inc

Duke Energy Corp

Abbvie Inc.

American Express Co.

Altria Group Inc.

Caterpillar, Inc.

Colgate-Palmolive Co

Exxon Mobil Corp.

ETC 6 Meridian Mega Cap Equity ETF

Recursion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.37) by 8.11 percent. The company reported quarterly sales of $26.082 million which missed the analyst consensus estimate of $29.843 million by 12.60 percent. This is a 147.62 percent increase over sales of $10.533 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

RXRX

Recursion Pharmaceuticals Q3 2024 GAAP EPS $(0.34) Beats $(0.37) Estimate, Sales $26.082M Miss $29.843M Estimate

TTEC Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEC#NASDAQ">TTEC</a>) lowers FY2024 Adj EPS guidance from $0.74-0.97 to $0.64-0.83 vs $0.80 analyst estimate. Affirms FY2024 sales outlook from $2.21 billion-2.26 billion to $2.21 billion-2.26 billion vs $2.22 billion estimate.

Guidance

TTEC

TTEC Holdings Lowers FY2024 Adj EPS Guidance from $0.74-0.97 to $0.64-0.83 vs $0.80 Est; Affirms FY2024 Sales Guidance from $2.21B-2.26B to $2.21B-2.26B vs $2.22B Est

Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) raises FY2024 Adj EPS guidance from $2.15-2.20 to $2.28-2.31 vs $2.17 analyst estimate. Raises FY2024 sales outlook from $833.00 million-837.00 million to $839.00 million-841.00 million vs $834.13 million estimate.

Rapid7 Raises FY2024 Adj EPS Guidance from $2.15-2.20 to $2.28-2.31 vs $2.17 Est; Raises FY2024 Sales Guidance from $833.00M-837.00M to $839.00M-841.00M vs $834.13M Est

Permian Resources Q3 Oil Sales $1.099B

Bridge Investment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) reported quarterly sales of $101.51 million which beat the analyst consensus estimate of $82.90 million by 22.44 percent. This is a 4.48 percent decrease over sales of $106.27 million the same period last year.

BRDG

Bridge Investment Group Q3 Sales $101.51M Beat $82.90M Estimate

CLOV

Clover Health Sees FY24 Adj. EBITDA Profitability $55M-$65M

Sterling Infrastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRL#NASDAQ">STRL</a>) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $1.71 by 15.2 percent. This is a 56.35 percent increase over earnings of $1.26 per share from the same period last year. The company reported quarterly sales of $593.74 million which missed the analyst consensus estimate of $613.63 million by 3.24 percent. This is a 5.96 percent increase over sales of $560.35 million the same period last year.

STRL

Sterling Infrastructure Q3 EPS $1.97 Beats $1.71 Estimate, Sales $593.74M Miss $613.63M Estimate

Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.06) by 100 percent. The company reported quarterly sales of $122.751 million which missed the analyst consensus estimate of $125.853 million by 2.47 percent. This is a 3.99 percent decrease over sales of $127.854 million the same period last year.

NDLS

Noodles Q3 2024 Adj. EPS $(0.12) Misses $(0.06) Estimate, Sales $122.751M Miss $125.853M Estimate

Crane NXT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXT#NYSE">CXT</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.14 by 1.75 percent. The company reported quarterly sales of $403.500 million which beat the analyst consensus estimate of $392.440 million by 2.82 percent. This is a 14.34 percent increase over sales of $352.900 million the same period last year.

Crane NXT Q3 2024 Adj. EPS $1.16 Beats $1.14 Estimate, Sales $403.500M Beat $392.440M Estimate

Brookdale Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent.

Brookdale Senior Living Q3 2024 Adj. EPS $(0.22) Misses $(0.17) Estimate

Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) raises FY2024 sales outlook from $432.00 million-438.00 million to $442.00 million-445.00 million.

VCYT

Veracyte Raises FY2024 Sales Guidance from $432.00M-438.00M to $442.00M-445.00M  VS Est. 436.14M

CLNE

Clean Energy Fuels Sees FY24 Adj. EBITDA $62M-$72M

VIZIO Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZIO#NYSE">VZIO</a>) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.02) by 105 percent. The company reported quarterly sales of $444.70 million which beat the analyst consensus estimate of $443.80 million by 0.20 percent. This is a 4.34 percent increase over sales of $426.20 million the same period last year.

VZIO

VIZIO Holding Q3 2024 GAAP EPS $0.00 Beats $(0.02) Estimate, Sales $444.70M Beat $443.80M Estimate

LiveRamp Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) raises FY2025 sales outlook from $715.00 million-735.00 million to $737.00 million-739.00 million.

RAMP

LiveRamp Holdings Raises FY2025 Sales Guidance from $715.00M-735.00M to $737.00M-739.00M

Clover Health Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOV#NASDAQ">CLOV</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. The company reported quarterly sales of $330.99 million which missed the analyst consensus estimate of $346.28 million by 4.42 percent. This is a 8.16 percent increase over sales of $306.03 million the same period last year.

Clover Health Investments Q3 2024 GAAP EPS $(0.02) Beats $(0.04) Estimate, Sales $330.99M Miss $346.28M Estimate

LiveRamp Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) sees Q3 sales of $191.000 million vs $188.55 million estimate.

LiveRamp Holdings Sees Q3 Sales $191.000M vs $188.55M Est

Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $(0.46) by 19.57 percent. This is a 89.66 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $1.39 million which missed the analyst consensus estimate of $1.48 million by 6.01 percent. This is a 30.98 percent increase over sales of $1.06 million the same period last year.

NYXH

Nyxoah Q3 EPS $(0.55) Misses $(0.46) Estimate, Sales $1.39M Miss $1.48M Estimate

Retail Sales

FTEK

Fuel Tech Inc Announced Orders From New And Existing Customers Totaling ~$2M

e.l.f. Beauty, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) shares are climbing after the company reported its second-quarter results after Wednesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/24/11/b41786513/e-l-f-beauty-announces-second-quarter-fiscal-2025-results">details from the report.  </a>
The Details: e.l.f. Beauty reported quarterly earnings of 77 cents per share, which beat the analyst consensus estimate of 42 cents. Quarterly revenue came in at $301.1 million, which beat the analyst consensus estimate of $285.76 million and is an increase over sales of $215.5 million from the same period last year.
e.l.f. said its gross margin increased approximately 40 basis points to 71%, primarily driven by cost savings, favorable foreign exchange impacts and price increases in the company&#8217;s international markets, partially offset by mix and higher transportation costs.
Read Next: <a href="https://www.benzinga.com/news/24/11/41781921/what-does-trumps-victory-mean-for-ev-giant-tesla-and-the-big-3-automakers">What Does Trump&#8217;s Victory Mean For EV Giant Tesla And The Big 3 Automakers?</a>
&#8220;Q2 marked another quarter of consistent, category-leading growth. In Q2, we delivered 40% net sales growth, fueled by 195 basis points of market share gains in the U.S. and 91% net sales growth internationally,&#8221; said Tarang Amin, e.l.f. Beauty&#8217;s CEO.
&#8220;This was our 23rd consecutive quarter of both net sales growth and market share gains. We continue to make progress across color cosmetics, skincare and international and believe our unique areas of advantage will fuel our ability to win in fiscal 2025 and beyond,&#8221; Amin added.
Outlook: e.l.f. Beauty raised its fiscal year 2025 net sales outlook to a range of $1.315 billion to $1.335 billion and now sees earnings of between $3.47 and $3.53 per share for the year.
ELF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, e.l.f. Beauty shares are up 13.24% after-hours at $117.95 at the time of publication Wednesday.
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a></li>
</ul>
Photo: Courtesy of E.l.f. Beauty, Inc.

Movers

e.l.f. Beauty Stock Soars After Strong Q2 Earnings Beat: Details

Cross Country Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. The company reported quarterly sales of $315.119 million which beat the analyst consensus estimate of $310.218 million by 1.58 percent. This is a 28.75 percent decrease over sales of $442.291 million the same period last year.

Comments

ETC 6 Meridian Mega Cap Equity ETF

Vendite allo scoperto

ETC 6 Meridian Mega Cap Equity ETF (ARCA:SIXA), Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO